Trial Profile
Phase II Evaluation of Trastuzumab (Herceptin), Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Advanced Urothelial Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Gemcitabine; Paclitaxel
- Indications Carcinoma; Urogenital cancer
- Focus Adverse reactions
- 20 Sep 2005 New trial record.